UK_FTS process · buyer country GB · planning
NHS National Framework for Macitentan tablets
NHS England
- Buyer
- NHS England
- Buyer identifier
- GB-PPON: PDPT-3135-BWWY
- Primary supplier
- Not reported
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- GBP 128,400,000
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
Project title: NHS National Framework Agreement for Macitentan & Cladribine Tablets Offer reference number: CM/TNS/26/5748 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5748/01 Macitentan Lot 1 DCE/DLN: 01/10/2027 to 30/09/2029 (24 months) CELN Lot 2 DNW/DLS: 01/10/2027 to 31/01/2029 (16 months) NWLS Lot 3 DNE/DSW: 01/10/2027 to 30/09/2029 (24 months) NESW CM/TNS/26/5748/02 Cladribine Tablets Lot 1 DCE/DSW: 01/10/2027 to 30/09/2029 (24 months) CESW Lot 2 DLN/DNW: 01/10/2027 to 31/01/2029 (16 months) NWLN Lot 3 DLS/DNE: 01/10/2027 to 30/09/2028 (12 months) LSNE Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Suppliers
Official lifecycle
Process timeline
- Source update
NHS National Framework Agreement for Macitentan & Cladribine Tablets
- Planned
NHS National Framework for Macitentan tablets
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|---|---|---|
| 104326-2026 | Nov 3, 2026 | planningUpdate | Nov 3, 2026 |
| 104267-2026 | Nov 3, 2026 | planning | Nov 3, 2026 |